Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Adjuvant therapy for gastric cancer after D2 gastrectomy.
Nishida T.
Lancet. 2012 Jan 28;379(9813):291-2. Epub 2012 Jan 7. No abstract available.
Related citations
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, Lee KW, Kim YH, Noh SI, Cho JY, Mok YJ, Kim YH, Ji J, Yeh TS, Button P, Sirzén F, Noh SH; CLASSIC trial investigators.
Lancet. 2012 Jan 28;379(9813):315-21. Epub 2012 Jan 7.
The value of the National Health and Nutrition Survey in Japan.
Sasaki S.
Lancet. 2011 Oct 1;378(9798):1205-6. Epub 2011 Aug 30. No abstract available.
Mass eradication of Helicobacter pylori: feasible and advisable?
Mazzoleni LE, Francesconi CF, Sander GB.
Lancet. 2011 Aug 6;378(9790):462-4. Epub 2011 Jul 21. No abstract available.
Error occurred: cannot get document summary
Trastuzumab for gastric cancer treatment.
Okines AF, Dewdney A, Chau I, Rao S, Cunningham D.
Lancet. 2010 Nov 20;376(9754):1736; author reply 1736-7. No abstract available.
Fujita T.
Lancet. 2010 Nov 20;376(9754):1735; author reply 1735-6. No abstract available.
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Rüschoff J, Kang YK; ToGA Trial Investigators.
Lancet. 2010 Aug 28;376(9742):687-97. Epub 2010 Aug 19. Erratum in: Lancet. 2010 Oct 16;376(9749):1302.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on